Evidence map›Paper›PMID 34667884›Full record

ArticleClinical and translational radiation oncology2021

A knowledge graph representation of baseline characteristics for the Dutch proton therapy research registry.

Matthijs Sloep, Petros Kalendralis, Ananya Choudhury, Lerau Seyben, Jasper Snel, Nibin Moni George, Martijn Veening, Johannes A Langendijk, Andre Dekker, Johan van Soest and 1 more

Abstract read
In one paragraph

Article in Clinical and translational radiation oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Matthijs SloepDepartment of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Petros KalendralisDepartment of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Ananya ChoudhuryDepartment of Radiation Oncology, University of Groningen, University Medical Centre Groningen. Groningen, The Netherlands.
Lerau SeybenDepartment of Radiation Oncology, University of Groningen, University Medical Centre Groningen. Groningen, The Netherlands.
Jasper SnelDepartment of Radiation Oncology, University of Groningen, University Medical Centre Groningen. Groningen, The Netherlands.
Nibin Moni GeorgeDepartment of Radiation Oncology, University of Groningen, University Medical Centre Groningen. Groningen, The Netherlands.
Martijn VeeningDepartment of Radiation Oncology, University of Groningen, University Medical Centre Groningen. Groningen, The Netherlands.
Johannes A LangendijkDepartment of Radiation Oncology, University of Groningen, University Medical Centre Groningen. Groningen, The Netherlands.
Andre DekkerDepartment of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Johan van SoestDepartment of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Rianne FijtenDepartment of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer registries collect multisource data and provide valuable information that can lead to unique research opportunities. In the Netherlands, a registry and model-based approach (MBA) are used for the selection of patients that are eligible for proton therapy. We collected baseline characteristics including demographic, clinical, tumour and treatment information. These data were transformed into a machine readable format using the FAIR (Findable, Accessible, Interoperable, Reusable) data principles and resulted in a knowledge graph with baseline characteristics of proton therapy patients. With this approach, we enable the possibility of linking external data sources and optimal flexibility to easily adapt the data structure of the existing knowledge graph to the needs of the clinic.

Identifiers

PMID34667884
PMCPMC8505268

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.